Navigation Links
Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
Date:8/11/2008

WALTHAM, Mass., Aug. 11 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, announced today that it has received licensure from the United States Department of Agriculture (USDA) to manufacture, market and distribute the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit. Test results are available in 15 minutes compared to traditional methods, which can take days to produce results.

Responding to a USDA-identified need for a rapid influenza test for veterinary use, Inverness sought and has now obtained USDA clearance for testing in avian species. Inverness is the only manufacturer to have two versions of their rapid antigen test kit for influenza: one USDA licensed for veterinary use and the other FDA cleared for human use.

The BinaxNOW AI Antigen Test is an easy-to-use, rapid immunochromatographic test (ICT) that detects influenza A nucleoproteins in chicken, turkey and duck samples. No specialized equipment or training is necessary. Use of the BinaxNOW AI test enables early and accurate identification of influenza A nucleoproteins, facilitating the implementation of appropriate and cost-effective action plans.

Worldwide, many strains of avian influenza virus (AIV) can cause varying degrees of disease in poultry. Some strains are extremely infectious and a fatal form of the disease can spread rapidly from flock to flock. The prominent subtypes of avian influenza viruses include H5 and H7. The BinaxNOW AI Antigen Test is capable of detecting all subtypes, including H5 and H7.

Effective and timely detection of AIV is not only important for the protection of animals and our food supply, but infections with these viruses can occur in humans. According to the CDC, the risk to humans from avian influenza is generally low. However, confirmed cases of human infection from several subtypes of avian influenza infection have been reported since 1997. Thus, early identification and effective management of infected animals may have important benefits for human health worldwide.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com .

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements regarding the potential benefits of the new product. These statements reflect Inverness' current views with respect to future events and are based on its management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks associated with market acceptance of the product; Inverness' ability to successfully manufacture and distribute the product; Inverness ability to secure and maintain the regulatory approvals or clearances necessary to sell the product in various markets; and the risks and uncertainties described in Inverness' annual report on Form 10-K, and other factors identified from time to time in its periodic filings with the Securities and Exchange Commission. Inverness undertakes no obligation to update any forward-looking statements contained herein.


'/>"/>
SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
2. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
3. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
4. Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
5. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
6. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
7. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
8. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
9. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
10. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
11. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology:
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):